80 related articles for article (PubMed ID: 21378353)
1. Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma.
Moertel S; Ackermann H; Baghi M; Eckardt A; Wagenblast J; Stöver T; Hambek M
Anticancer Res; 2011 Feb; 31(2):665-9. PubMed ID: 21378353
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
4. Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
Fischer CA; Jung M; Zlobec I; Green E; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
Head Neck; 2011 Feb; 33(2):267-73. PubMed ID: 20848449
[TBL] [Abstract][Full Text] [Related]
5. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
8. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
9. Validation of tissue array technology in head and neck squamous cell carcinoma.
Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
[TBL] [Abstract][Full Text] [Related]
10. Correlation of biomarkers in head and neck squamous cell carcinoma.
Tse GM; King AD; Yu AM; Lam CC; Chan AW; Chen GG; Yeung DK; Yu KH; Bhatia KS; Chan AB
Otolaryngol Head Neck Surg; 2010 Dec; 143(6):795-800. PubMed ID: 21109080
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
13. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
14. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study.
Flezar MS; Kirbis IS; Popović KS; Strojan P
Radiother Oncol; 2009 Dec; 93(3):575-80. PubMed ID: 19850367
[TBL] [Abstract][Full Text] [Related]
16. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
Ang KK; Berkey BA; Tu X; Zhang HZ; Katz R; Hammond EH; Fu KK; Milas L
Cancer Res; 2002 Dec; 62(24):7350-6. PubMed ID: 12499279
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
Grandis JR; Tweardy DJ
Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
[TBL] [Abstract][Full Text] [Related]
19. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
[TBL] [Abstract][Full Text] [Related]
20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]